These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9657441)

  • 1. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR; Bock PE
    Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition.
    Zingali RB; Jandrot-Perrus M; Guillin MC; Bon C
    Biochemistry; 1993 Oct; 32(40):10794-802. PubMed ID: 8399228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of bothrojaracin with prothrombin.
    Zingali RB; Bianconi ML; Monteiro RQ
    Haemostasis; 2001; 31(3-6):273-8. PubMed ID: 11910195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Kirszberg C; Rumjanek VM; Monteiro RQ
    Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom.
    Arocas V; Castro HC; Zingali RB; Guillin MC; Jandrot-Perrus M; Bon C; Wisner A
    Eur J Biochem; 1997 Sep; 248(2):550-7. PubMed ID: 9346315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct thrombin inhibitors.
    Maffrand JP
    Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bothrojaracin interaction with human prothrombin.
    Monteiro RQ; Bock PE; Bianconi ML; Zingali RB
    Protein Sci; 2001 Sep; 10(9):1897-904. PubMed ID: 11514680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
    Ofosu FA
    Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin specificity.
    Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
    Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.